Abstract
Although there is substantial evidence that pneumolysin is an important virulence factor in pneumococcal pneumonia, relatively little is known about how it influences cellular infiltration into the lungs. We investigated how the inability of mutant pneumococci to produce pneumolysin altered the pattern of inflammation and cellular infiltration into the lungs. The effect on bacterial growth in the lungs also was assessed. There were three phases of growth of wild-type bacteria in the lungs: a decline followed by a rapid increase and then stasis or decline. The absence of pneumolysin was associated with a more rapid early decline and then a much slower increase in numbers. The pattern of inflammatory-cell accumulation also had distinct stages, and the timing of these stages was influenced by the presence of pneumolysin. Neutrophils began to accumulate about 12 to 16 h after infection with wild-type pneumococci. This accumulation occurred after the early decline in pneumococcal numbers but coincided with the period of rapid growth. Following infection with pneumococci unable to make pneumolysin, neutrophil influx was slower and less intense. Coincident with the third stage of pneumococcal growth was an accumulation of T and B lymphocytes at the sites of inflammation, but the accumulation was not associated with an increase in the total number of lymphocytes in the lungs. Lymphocyte accumulation in the absence of pneumolysin occurred but was delayed.
MeSH Terms
Animals
Bacterial Proteins
Female
Immunohistochemistry
Leukocyte Count
Lung/microbiology,pathology
Mice
Neutrophils/physiology
Pneumonia, Pneumococcal/immunology
Streptococcus pneumoniae/growth & development
Streptolysins/physiology
Chemicals
Bacterial Proteins
Streptolysins
plY protein, Streptococcus pneumoniae
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Kadioglu A
Department of Microbiology & Immunology, University of Leicester, Leicester, United Kingdom.
Gingles N A
Grattan K
Kerr A
Mitchell T J
Andrew P W
References (20)
20 references, click to expand
-
Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.
Infect Immun. 1983 Sep;41(3):1212-6
PMID: 6885160
-
Steroid pulse therapy for rheumatoid arthritis: effect on lymphocyte subsets and mononuclear cell adhesion.
Br J Rheumatol. 1998 Mar;37(3):282-6
PMID: 9566668
-
Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays.
Immunology. 1985 Jan;54(1):139-47
PMID: 2982730
-
Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin.
Immunology. 1986 Dec;59(4):515-20
PMID: 3804376
-
Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies.
Immunology. 1987 Nov;62(3):349-56
PMID: 3499375
-
Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.
Infect Immun. 1989 Jul;57(7):2037-42
PMID: 2731982
-
The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro.
Microb Pathog. 1990 Oct;9(4):275-84
PMID: 2097494
-
Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein.
Mol Microbiol. 1991 Aug;5(8):1883-8
PMID: 1766369
-
The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro.
Eur Respir J. 1992 May;5(5):576-83
PMID: 1612157
-
Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes.
Infect Immun. 1994 Apr;62(4):1501-3
PMID: 8132361
-
Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans.
Lab Invest. 1994 Jul;71(1):113-26
PMID: 8041111
-
Pneumolysin activates phospholipase A in pulmonary artery endothelial cells.
Infect Immun. 1994 Sep;62(9):3829-36
PMID: 8063399
-
Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.
Infect Immun. 1994 Dec;62(12):5683-8
PMID: 7960154
-
Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia.
J Clin Invest. 1995 Jan;95(1):142-50
PMID: 7814608
-
Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa.
Infect Immun. 1995 Feb;63(2):442-7
PMID: 7822008
-
A pneumolysin-negative mutant of Streptococcus pneumoniae causes chronic bacteremia rather than acute sepsis in mice.
Infect Immun. 1995 Feb;63(2):448-55
PMID: 7822009
-
The role of pneumolysin and autolysin in the pathology of pneumonia and septicemia in mice infected with a type 2 pneumococcus.
J Infect Dis. 1995 Jul;172(1):119-23
PMID: 7797901
-
The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection.
J Immunol. 1995 Nov 15;155(10):4790-7
PMID: 7594481
-
Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice.
Infect Immun. 1998 Mar;66(3):912-22
PMID: 9488375
-
Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia.
Microb Pathog. 1998 Mar;24(3):167-74
PMID: 9514638